Biocon Ltd.

Biocon is a biotechnology major with businesses in biosimilars, generics, and research services (Syngene stake). ​ It is a key Indian player in insulin and complex biologics targeting global markets. ​ The biosimilars portfolio offers long‑run growth but has high regulatory and execution complexity. ​ Pressure in US generics and high R&D/ capex keep near‑term earnings volatile. ​